Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Centre, Open Label, Parallel Group, Randomized Controlled Trial to Compare the Safety and Efficacy of Oral Paricalcitol Versus Oral Calcitriol in the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

NCT00800358 is registered in ClinicalTrials.gov with Penang Hospital, Malaysia as lead sponsor.

NCT NCT00800358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00800358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Centre, Open Label, Parallel Group, Randomized Controlled Trial to Compare the Safety and Efficacy of Oral Paricalcitol Versus Oral Calcitriol in the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
Lead sponsor
Penang Hospital, Malaysia
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2008
Completion date
December 31, 2009
Enrollment
69 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hyperparathyroidism, kidney disease